ED
HBM icon

Exane Derivatives’s Hudbay HBM Stock Holding History

Exane Derivatives’s Portfolio HBM Stock Details HBM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-4,800
Closed -$34.6K – 1046
2021
Q4 		$34.6K Hold
4,800
– – 0.01% 543
2021
Q3 		$29.8K Hold
4,800
– – 0.01% 666
2021
Q2 		$33.2K Hold
4,800
– – 0.01% 674
2021
Q1 		$32.7K Hold
4,800
– – 0.01% 543
2020
Q4 		$33.6K Buy
+4,800
New +$27.1K 0.01% 490

Other funds holding HBM

WGRM
Waterton Global Resource Management Toronto, Ontario, Canada $64.9M AUM 17.81% 1-Year Est. Return
GC
GMT Capital Atlanta, Georgia $1.92B AUM 70.51% 1-Year Est. Return
LBA
Letko, Brosseau & Associates Montreal, Quebec, Canada $6.77B AUM 38.11% 1-Year Est. Return
LC
L1 Capital Melbourne VIC 3000, Australia $2.97B AUM 43.46% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Mirae Asset Global Investments
Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 57.61% 1-Year Est. Return
CM
Condire Management Dallas, Texas $942M AUM 83.43% 1-Year Est. Return
HCM
Heathbridge Capital Management Toronto, Ontario, Canada $292M AUM 21.77% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Exane Derivatives's HBM Position: Q1 2022 in Review

Exane Derivatives sold out of Hudbay (HBM) in Q1 2022, closing a stake of 4,800 shares — an estimated $34.6K sold.

Exane Derivatives first reported a position in HBM in Q4 2020 and held it in 5 quarters. The position peaked at $34.6K in Q4 2021. 138 funds tracked by Wall St. Rank hold HBM as of Q1 2022.

  • Exane Derivatives reported no remaining Hudbay position as of Q1 2022 after selling out during the quarter.
  • Exane Derivatives sold 4,800 Hudbay shares in Q1 2022, an estimated $34.6K.
  • Exane Derivatives first reported a position in Hudbay in Q4 2020 and held it in 5 quarters.
  • Exane Derivatives's Hudbay position peaked at $34.6K in Q4 2021.
  • 138 funds tracked by Wall St. Rank held Hudbay as of Q1 2022.

Based on Exane Derivatives's 13F filing for Q1 2022, filed 22 Apr 2022.